Wedbush Securities’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,138	Closed	-$203K	–	1218
2025 Q3	$203K	Buy	+3,138	New	+$180K	0.01%	1072
2024 Q3	–	Sell	-5,677	Closed	-$307K	–	1133
2024 Q2	$307K	Buy	5,677 +366	+7%	+$21.2K	0.01%	851
2024 Q1	$362K	Buy	5,311 +1,153	+28%	+$82.5K	0.01%	780
2023 Q4	$260K	Buy	+4,158	New	+$230K	0.01%	833
2023 Q3	–	Sell	-3,767	Closed	-$211K	–	1064
2023 Q2	$211K	Sell	3,767 -1,188	-24%	-$67.4K	0.01%	909
2023 Q1	$224K	Buy	+4,955	New	+$241K	0.01%	893
2022 Q4	–	Sell	-5,656	Closed	-$370K	–	1067
2022 Q3	$370K	Sell	5,656 -3,043	-35%	-$221K	0.02%	629
2022 Q2	$529K	Hold	8,699	–	–	0.03%	510
2022 Q1	$546K	Sell	8,699 -506	-5%	-$31.8K	0.03%	540
2021 Q4	$698K	Buy	9,205 +910	+11%	+$79.5K	0.03%	497
2021 Q3	$928K	Sell	8,295 -263	-3%	-$33K	0.04%	379
2021 Q2	$1.39M	Sell	8,558 -101	-1%	-$12.3K	0.07%	278
2021 Q1	$1.05M	Buy	+8,659	New	+$1.31M	0.06%	314